Call to Schedule Free Consultation at Over 80 Centers Worldwide!

(844) GET-STEM

Breaking the Cycle of Hidradenitis Suppurativa: A Modern Look at Regenerative Therapies

Written by Dr. David Greene, MD, PhD, MBA on October 23, 2026

Table of Contents

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that causes painful nodules, abscesses, and draining tunnels under the skin. It most often appears in the armpits, groin, buttocks, and inner thighs. If you live with HS, you know flare-ups can disrupt sleep, work, relationships, and confidence.

Standard HS treatment focuses on controlling symptoms. Researchers are now studying whether regenerative medicine, including mesenchymal stem cells (MSCs) and exosomes, could address the immune signaling behind the disease. This guide explains how these therapies work, what the evidence shows, and how to evaluate your options.

What Causes Hidradenitis Suppurativa?

HS is not a simple skin infection and it is not caused by poor hygiene. It begins as an inflammatory condition around the hair follicle. Researchers believe an overactive immune response, involving T-cell subsets and inflammatory cytokines such as TNF-alpha and IL-17, keeps inflammation going long after the initial trigger.

Over time, repeated flares can damage deeper tissue and formsinus tracts (tunnels) that drain fluid and rarely heal on their own. Understanding this cycle is key to understanding why treatments differ.

Conventional Hidradenitis Suppurativa Treatment Options

Current HS treatments aim to reduce inflammation, manage pain, and remove damaged tissue:

Long-term antibiotics: Often prescribed for their anti-inflammatory effect, not only for infection. Prolonged use can affect the gut and skin microbiome.

Biologic medications: These target specific inflammatory pathways, such as TNF-alpha or IL-17. Several are approved for HS, but response varies from person to person.

Surgery: Unroofing, excision, and laser procedures remove affected tissue. They treat localized disease but do not change the underlying immune activity, so new lesions can still form.

Many patients find these options helpful but incomplete, especially in moderate to severe disease. That gap is why researchers are exploring newer approaches.

How Stem Cell and Exosome Therapy Work

Regenerative therapies work differently from traditional drugs. Rather than blocking one pathway or removing tissue, they aim to influence cell signaling.

Mesenchymal stem cells (MSCs) respond to the environment they enter. In inflamed tissue, they release signaling proteins that may help rebalance overactive T-cell responses without shutting down the whole immune system. Learn more about how stem cells affect the immune system.

Exosomes are tiny vesicles released by cells that carry RNA, proteins, and growth factors to neighboring cells. Researchers are studying whether they can encourage tissue repair around chronic tunnels and fistulas. See our guide on how exosomes fit into regenerative therapy.

Cytokine modulation: By lowering local inflammatory signaling, these therapies aim to create conditions where healthy tissue can recover. For background, read about understanding cytokines.

What the Research Says So Far

The science is promising but early, and it’s important to be clear about where it stands.

Preclinical studies: Lab and animal research shows MSCs can modulate inflammatory pathways and limit tissue breakdown.

Related conditions: MSCs have been studied for complex fistulas in conditions such as Crohn's disease. Results have been mixed, but this work is the main reason researchers are interested in applying MSCs to HS tunnels.

HS-specific evidence: Large, double-blind randomized controlled trials for HS are still lacking. Most current information comes from early-phase studies, case reports, and clinical observation.

Regulatory status: In the United States, the FDA has not approved stem cell or exosome products for treating HS. Be cautious of any provider who promises a cure or guaranteed results.

Questions to Ask Before Considering Regenerative Therapy

If your HS hasn’t responded to standard care, talk with your dermatologist first. If you then explore regenerative options, ask any clinic:

Is the treatment part of a registered clinical trial (check ClinicalTrials.gov)?

What is the source and processing of the cells or exosomes, and is it FDA-compliant?

What published evidence supports its use for HS specifically?

What are the risks, costs, and realistic outcomes?

Will my dermatologist be kept informed of my care?

For more help, see our guide on how to choose the right stem cell clinic.

Talk to R3 Stem Cell About Your Options

R3 Stem Cell offers a complimentary consultation to discuss whether cellular or exosome-based protocols may be appropriate for your situation. Results vary, and these therapies are not FDA-approved for HS.

Call: +1 844-GET-STEM

Included: A no-cost candidate evaluation

Resources: Educational materials, including Stem Cell Genius, are available on request during your consultation

Frequently Asked Questions

Can stem cells cure hidradenitis suppurativa?

No cure currently exists. Stem cell therapy for HS is investigational, and research is still early.

Is exosome therapy for HS FDA-approved?

No. The FDA has not approved exosome products for HS, so discuss risks and evidence carefully with a qualified physician.

Can regenerative medicine replace biologics or surgery?

Not at this time. Any decision to change your treatment plan should involve your dermatologist.

Who might be a candidate?

Typically, people with persistent or severe HS who haven’t responded well to standard care. A medical evaluation is needed to determine suitability.

Disclaimer: This article is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before making treatment decisions.

Contact Us